Expected earnings - NervGen Pharma Corp.
Source: Canadian Earnings Reports
NervGen Pharma Corp. (NGEN:CA) is expected to report $-0.05 for Q4 2025
Nervgen Pharma Corp.
NASDAQ: NGEN:CC
NGEN:CC Trading
-6.67% G/L:
$2.24 Last:
40,579 Volume:
$2.34 Open:
